International Research journal of Management Science and Technology

  ISSN 2250 - 1959 (online) ISSN 2348 - 9367 (Print) New DOI : 10.32804/IRJMST

Impact Factor* - 6.2311


**Need Help in Content editing, Data Analysis.

Research Gateway

Adv For Editing Content

   No of Download : 77    Submit Your Rating     Cite This   Download        Certificate

THE PERCEPTION OF COMMON MAN TOWARD AYURVEDIC ADVERTISEMENT IN CURING CHRONIC AILMENTS

    2 Author(s):  DR. GAURAV PANDE, MISS MONTIRA APHISIRIPANYA

Vol -  8, Issue- 4 ,         Page(s) : 93 - 99  (2017 ) DOI : https://doi.org/10.32804/IRJMST

Abstract

According to the Drug and cosmetic act & rule (DCA&R), 1940 the Manufacturing, sale and distribution of Ayurvedic drug and cosmetics product are fully enforced. The Ayurvedic manufacture may not claim the prevention or treatment one or more diseases / disorder specified in the act Schedule H and Schedule X. For instance bronchial Asthma, Cancer and Benign tumor, Diabetes, Leucoderma, Obesity, etc. Any claimed which disobey an act is considered as misleading advertisement. Most of diseases mentioned above are considered as chronic ailments which cannot make therapeutic claimed in advertised drug. Then do people believe the message in advertised Ayurvedic drug? The finding of this study found out that most respondents do aware about the misleading claimed in Ayurvedic medicine advertisements. However, most people 30 (60%) agreed that Information provided in the Advertisement is reliable. Furthermore, the result revealed that 31(62%) of respondents believed the claimed in Ayurvedic medicine that it is able to relief, treat chronic ailments. From the data collection, the most reliability source of information is family (37 %) and relative (22 %) respectively. Whereas the less reliable of information regarding Ayurvedic medicine were belong to Retailer (29%) and internet (23%) source of information.

  1. Abel GA, Penson RT, Joffe S, et al. Direct-to-consumer advertising in oncology. Oncologist. 2006;11(2):217–226.
  2. AL, C. (2009). Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics. Albany Law Rev , 73 (1), 243-82.
  3. Bulletin of the World Health Organization. (2009, August 8). Direct-to-consumer advertising under fire. Bulletin of the World Health Organization , 87, pp. 565-644.
  4. Department of Consumer Affairs Ministry of Consumer Affairs, Food & Public Distribution. (n.d.). Voluntary Consumer Organisations. Retrieved August 2017, from Grievances Against Misleading Advertisements (GAMA) website: http://gama.gov.in/VCO.aspx
  5. DL, F. (2007). Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Ann Fam Med. , 5 (1), 6-13.
  6. economictimes. (2016, June ). FSSAI signs pact with ASCI to check misleading advertisements . Retrieved December 2016, from economictimes: https://economictimes.indiatimes.com/industry/services/advertising/fssai-signs-pact-with-asci-to-check-misleading-advertisements/articleshow/52959167.cms
  7. Faerber, A. E. (2014). Content Analysis of False and Misleading Claims in Television Advertising for Prescription and Nonprescription Drugs. Journal of General Internal Medicine , 110-118.
  8. FICCI Survey. Survey on Advertising Standards in India: An Introduction. Federation of Indian Chambers of Commerce and Industry.
  9. Khosla, P., & Khosla, A. (2011). Direct to consumer advertising of prescription drugs on internet: A Boon or a Curse. Indian J Pharmacol , 43 (4), 483–484.
  10. McGraw-Hill Concise Dictionary of Modern Medicine. (2002). McGraw-Hill Concise Dictionary of Modern Medicine. Retrieved October 2016, from http://medical-dictionary.thefreedictionary.com
  11. Misleading ads for traditional medicine under Centre’s scanner. (2017, January 21). Retrieved from The Hindu Website: http://www.thehindu.com/business/Industry/Misleading-ads-for-traditional-medicine-under-Centre%E2%80%99s-scanner/article17074731.ece
  12. Patwardhan, B. (2016). Ayurvedic drugs in case: Claims, evidence, regulations and ethics. J Ayurveda Integr Med , 7 (3), 135–137.
  13. Patwardhan, B. (2016). Ayurvedic drugs in case: Claims, evidence, regulations and ethics. Journal of Ayurveda and Integrative Medicine , 135-137.
  14. The Advertising Standards Council of India (ASCI). (2017, March 31). 31st Report & Accounts of 2016-17. Retrieved August 2017, from The Advertising Standards Council Of India website: https://www.ascionline.org/index.php/press-releases.html
  15. the Advertising Standards Council of India (ASCI). (2017). Consumer Complaints Council Recommendation of 2016-2017. 
  16. The hindu businessline. (2015, December 22). Kerala files 25 cases against herbal product claims. Retrieved March 2016, from thehindubusinessline: http://www.thehindubusinessline.com/news/national/kerala-files-25-cases-against-herbal-product-claims/article8018782.ece
  17. Ventola, C. L. (2011). Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic? Pharmacy and Therapeutics , 669-674, 681-684.
  18. Yadav, M., & Ali, I. (2015). a study of consumer perception of herbal products in bhopal (with special reference to vindhya herbal products). International Journal of Management Studies , 69-80.

*Contents are provided by Authors of articles. Please contact us if you having any query.






Bank Details